Stay updated on Pembrolizumab in EOC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in EOC Clinical Trial page.

Latest updates to the Pembrolizumab in EOC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, reflecting an update to the page's underlying system version. This is a maintenance change and does not modify study details, eligibility criteria, or results.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe revision label on the page was updated to v3.6.4, signaling a small patch or update to the documented content.SummaryDifference0.1%

- Check49 days agoChange DetectedPage revision updated to v3.6.3, indicating a small update to the page's underlying template/assets; no study content changes are reflected in this update.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page's revision label at the bottom was updated from Revision: v3.6.0 to Revision: v3.6.2, signaling a minor metadata update to the study record page.SummaryDifference0.1%

- Check71 days agoChange DetectedThe study page now indicates the trial is no longer recruiting. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated with a new page revision noted as v3.6.0.SummaryDifference0.5%

- Check78 days agoChange DetectedThe page's revision tag was updated to v3.5.5, indicating a small internal update to the page's documentation or rendering.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in EOC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in EOC Clinical Trial page.